Which Fund Has The Most To Gain From Biogen Idec?

By: via Benzinga
The S&P medical sector is still leaving the competition in the dust. Using the Health Care SPDR ETF (NYSE: XLV) as a proxy, the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.